Clinical Trial

ESPB vs SPSIP for Postoperative Analgesia After CABG

Study acronym: ESP-SPSIP-CABG
Recruiting
View on ClinicalTrials.gov →
Summary
This prospective, randomized, active-controlled, double-blind, parallel-group study compares the postoperative analgesic efficacy and safety of ultrasound-guided bilateral Erector Spinae Plane Block (ESPB) versus bilateral Serratus Posterior Superior Intercostal Plane Block (SPSIPB) in adult patients (45-85 years, ASA I-III) undergoing elective coronary artery bypass graft surgery. The primary outcome is postoperative pain intensity assessed by Numeric Rating Scale (NRS) at 2, 4, 8, 16, 24, and 48 hours after surgery. Secondary outcomes include intraoperative fentanyl/remifentanil consumption, postoperative morphine consumption, patient-controlled analgesia (PCA) demand/delivery parameters (if PCA is used), need for rescue analgesics, extubation and mobilization times, peak inspiratory flow measured by incentive spirometry at predefined time points, ICU and hospital length of stay, recovery quality (QoR-15 at 0, 24, and 48 hours), mortality, and block-related adverse events.
Protocol Amendment History 3 changes
notable Primary completion pushed: 2026-06-30 -> 2026-09-30 2026-08-06
minor Completion pushed: 2026-08-31 -> 2026-09-30 2026-08-06
critical Recruitment opened 2026-05-14
Trial Details
NCT Number NCT07388745
Lead Sponsor Kutahya Health Sciences University
Conditions Coronary Arterial Disease, Coronary Artery Bypass Grafting (CABG) Surgery, Postoperative Pain Management
Enrollment 64 participants
Start Date 2026-03-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-05